These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 6573569)
21. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A]. Beck JD Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845 [TBL] [Abstract][Full Text] [Related]
22. Chemotherapy of haematological malignancies. Prognostic significance. Klener P Acta Univ Carol Med Monogr; 1979; 90():7-127. PubMed ID: 400423 [No Abstract] [Full Text] [Related]
23. Treatment of acute leukemia with amsacrine and high-dose cytarabine. Arlin ZA; Gaddipati J; Ahmed T; Mittelman A; Friedland M; Rieber E Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713 [TBL] [Abstract][Full Text] [Related]
24. Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. Preisler H; Barcos M; Reese P; Priore RL; Pothier L Leuk Res; 1983; 7(1):67-75. PubMed ID: 6572773 [TBL] [Abstract][Full Text] [Related]
25. [Research on optimal dosage schemes in clinical experimentation with antineoplastic agents]. Praga C Boll Chim Farm; 1972 Feb; 111(2):93-9. PubMed ID: 4505372 [No Abstract] [Full Text] [Related]
26. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy]. Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580 [TBL] [Abstract][Full Text] [Related]
27. In vitro assessment of drug sensitivity in acute nonlymphocytic leukemia. Preisler HD; Raza A Recent Results Cancer Res; 1984; 94():102-15. PubMed ID: 6593774 [No Abstract] [Full Text] [Related]
29. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)]. Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970 [No Abstract] [Full Text] [Related]
30. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside. Cassileth PA; Katz ME Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749 [TBL] [Abstract][Full Text] [Related]
31. Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric study. Mandelli F; Amadori S; Fabiani F; Grignani F; Liso V; Martelli M; Neri A; Petti MC; Tonato M Haematologica; 1979 Jun; 64(3):331-8. PubMed ID: 113301 [No Abstract] [Full Text] [Related]
36. [Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, vincristine and prednisolone (author's transl)]. Yamaguchi H; Okabe N; Inoue A; Ichimaru M Rinsho Ketsueki; 1975 Jun; 16(6):589-98. PubMed ID: 1172055 [No Abstract] [Full Text] [Related]
37. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)]. Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683 [No Abstract] [Full Text] [Related]
38. [DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)]. Morishima Y; Yamada K; Kawashima K; Ohno R; Ezaki K; Kodera Y; Kobayashi M; Takeyama H; Kato Y; Watanabe E; Suzuki H; Yamaguchi H; Tanimoto M; Minami S; Yokomaku S; Ogura M; Morishita T; Nishiwaki H; Yamada H; Ohara K; Yoshikawa S Rinsho Ketsueki; 1980 Jan; 21(1):33-8. PubMed ID: 7373867 [No Abstract] [Full Text] [Related]
39. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group. Bodey GP; Coltman CA; Hewlett JS; Freireich EJ Arch Intern Med; 1976 Dec; 136(12):1383-8. PubMed ID: 1069570 [No Abstract] [Full Text] [Related]
40. [Effectiveness of low dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes--analysis of factors influencing the duration of responses, survival and clinical effects]. Sawada H; Abe T; Akasaka K; Ishikura H; Izumi Y; Inamoto Y; Usui T; Okazaki T; Okada H; Katoh Y Rinsho Ketsueki; 1987 Sep; 28(9):1553-60. PubMed ID: 3437517 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]